Literature DB >> 6224882

Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.

A G Rolink, E Gleichmann.   

Abstract

Previous work from this laboratory has led to the hypothesis that the stimulatory pathological symptoms of chronic graft-vs.-host disease (GVHD) are caused by alloreactive donor T helper (TH) cells, whereas the suppressive pathological symptoms of acute GVHD are caused by alloreactive T suppressor (TS) cells of the donor. In the present paper we analyzed the Lyt phenotypes of B10 donor T cells required for the induction of either acute or chronic GVHD in H-2-different (B10 X DBA/2)F1 recipients. First, nonirradiated F1 mice were used as the recipients. We found that unseparated B10 T cells induced only a moderate formation of systemic lupus erythematosus (SLE)-like autoantibodies, but a high percentage of lethal GVHD (LGVHD). In contrast, Lyt-1+2- donor T cells were unable to induce LGVHD in these recipients; these cells were capable, however, of inducing a vigorous formation of SLE-like autoantibodies and the formation of severe immune-complex glomerulonephritis. Lyt-1-2+ T cells were incapable of inducing either acute or chronic GVHD. In another experiment, the sensitivity and accuracy of the GVH system were increased by using irradiated F1 mice as recipients and by comparing donor-cell inocula that contained similar numbers of T lymphocytes. In addition, donor-cell inocula were used that had been tested for their allohelper and allosuppressor effects on F1 B cells in vitro. In the irradiated F1 recipients, too, unseparated donor T cells were superior to T cell subsets in inducing LGVHD; Lyt-1-2+ donor cells were completely and Lyt-1+2- donor cells were almost incapable of doing so. In contrast, Lyt-1+2- T cells, but neither unseparated T cells nor Lyt-1-2+ T cells, were capable of inducing a vigorous formation of SLE-like auto-antibodies. We conclude that the stimulatory pathological symptoms of chronic GVHD are caused by Lyt-1+2- allohelper T cells. In contrast, the development of the suppressive pathological symptoms of acute GVHD appears to involve alloreactive Lyt-1+2+ T suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224882      PMCID: PMC2187357          DOI: 10.1084/jem.158.2.546

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse.

Authors:  P Kisielow; J A Hirst; H Shiku; P C Beverley; M K Hoffman; E A Boyse; H F Oettgen
Journal:  Nature       Date:  1975-01-17       Impact factor: 49.962

2.  Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA).

Authors:  J H ten Veen; T E Feltkamp
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

3.  Hypothesis: a model for generalised autoimmunity.

Authors:  P Bretscher
Journal:  Cell Immunol       Date:  1973-01       Impact factor: 4.868

Review 4.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

5.  Intra-H-2 and T cell requirements for the induction of maximal positive and negative allogeneic effects in vitro.

Authors:  A G Rolink; W Van der Meer; C J Melief; E Gleichmann
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

Review 6.  Cellular immunology and the pathogenesis of graft versus host reactions.

Authors:  W L Elkins
Journal:  Prog Allergy       Date:  1971

7.  Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

Authors:  E L Reinherz; R Geha; J M Rappeport; M Wilson; A C Penta; R E Hussey; K A Fitzgerald; J F Daley; H Levine; F S Rosen; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

8.  Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.

Authors:  U Hurtenbach; G M Shearer
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Synergy among lymphoid cells mediating the graft-versus-host response. IV. Synergy in the GVH reaction quantitated by a mortality assay in sublethally irradiated recipients.

Authors:  R E Tigelaar; R Asofsky
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

10.  Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.

Authors:  A G Rolink; S T Pals; E Gleichmann
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  41 in total

1.  Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.

Authors:  Anthony D Foster; Mark Haas; Irina Puliaeva; Kateryna Soloviova; Roman Puliaev; Charles S Via
Journal:  Clin Immunol       Date:  2010-05-06       Impact factor: 3.969

2.  Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

Authors:  L Rozendaal; S T Pals; E Gleichmann; C J Melief
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 3.  Effect of graft-versus-host reaction on thymic function.

Authors:  M Fukuzawa; G M Shearer
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 4.  Advances in lupus stemming from the parent-into-F1 model.

Authors:  Charles S Via
Journal:  Trends Immunol       Date:  2010-03-31       Impact factor: 16.687

5.  Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.

Authors:  R J North; E S Dye
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

Review 6.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

7.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

Review 8.  Murine models of chronic graft-versus-host disease: insights and unresolved issues.

Authors:  Yu-Waye Chu; Ronald E Gress
Journal:  Biol Blood Marrow Transplant       Date:  2008-02-13       Impact factor: 5.742

9.  Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.

Authors:  Y Ikarashi; K Kawai; H Watanabe; Y Matsumoto; S Omata; M Fujiwara
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody.

Authors:  Alistair Noble; Jamie A Leggat; Else M Inderberg
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.